{"mainPropery":{"diseaseId":10175,"diseaseName":"Klatskin tumor","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/10175/klatskin-tumor","synonyms":["Klatskin's tumor","Perihilar cholangiocarcinoma"],"synonyms-with-source":[{"name":"Klatskin's tumor"},{"name":"Perihilar cholangiocarcinoma","source":""}],"identifiers":[{"identifierType":"ORPHANET","identifierId":"99978"},{"identifierType":"UMLS","identifierId":"C0206702"}]},"diseaseCategories":[{"diseaseTypeId":6,"diseaseTypeName":"Digestive Diseases","source":"Orphanet"},{"diseaseTypeId":1,"diseaseTypeName":"Rare Cancers"}],"organizations":[],"resource descriptions":[{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=PureSearch&db=pubmed&details_term=%28Klatskin%5BTitle%5D%20AND%20tumor%5BTitle%5D%29%20AND%20hasabstract%5Btext%5D' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Klatskin tumor. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='http://www.clinicaltrials.gov/ct2/results?cond=%22Klatskin+tumor%22' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to Klatskin tumor. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":10,"resourceId":13,"resourceName":"MedlinePlus Genetics","descriptionText":"<a href='https://ghr.nlm.nih.gov/condition/cholangiocarcinoma' target='_blank'>Genetics Home Reference (GHR)</a> contains information on Klatskin tumor. This website is maintained by the National Library of Medicine.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1531,"resourceId":2162,"resourceName":"Medscape Reference","descriptionText":"<a href='http://emedicine.medscape.com/article/277393-overview' target='_blank'>Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1532,"resourceId":2163,"resourceName":"Social Security Administration","descriptionText":"The <a href='https://secure.ssa.gov/apps10/poms.nsf/lnx/0423022175' target='_blank'>Social Security Administration</a> has included this condition in their Compassionate Allowances Initiative. This initiative speeds up the processing of disability claims for applicants with certain medical conditions that cause severe disability. More information about <a href=\"http://www.ssa.gov/compassionateallowances/index.htm\" target=\"_blank\">Compassionate Allowances</a> and <a href=\"https://www.ssa.gov/benefits/disability/\" target=\"_blank\">applying for Social Security disability</a> is available online.","resourceClassificationName":"Living With","resourceClassificationSectionName":"Financial Resources"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=99978' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1543,"resourceId":2171,"resourceName":"National Cancer Institute","descriptionText":"The <a href='https://www.cancer.gov/types/liver/patient/bile-duct-treatment-pdq' target='_blank'>National Cancer Institute</a> provides the most current information on cancer for patients, health professionals, and the general public.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1553,"resourceId":2171,"resourceName":"National Cancer Institute","descriptionText":"The <a href='http://cis.nci.nih.gov' target='_blank'>National Cancer Institute</a> (CIS)  provides the most current information on cancer for patients, health professionals, and the general public. You can reach them by calling toll-free at 1-800-422-6237 or by visiting their Web site. ","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/DOID:4927' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":4908,"questionText":"What&nbsp;are Klatskin tumors?","answerText":"<strong>Klatskin tumors</strong> are are a type of <a href=\"https://ghr.nlm.nih.gov/condition/cholangiocarcinoma\" target=\"_blank\">cholangiocarcinoma</a> that begins in an area called the hilum, where the left and right bile ducts join and leave the liver. It is the most common type of cholangiocarcinoma, accounting for more than half of all cases.[3898][3899][12368][12369] Symptoms usually don't present until advanced stages of disease, when <a href=\"https://medlineplus.gov/jaundice.html\" target=\"_blank\">jaundice</a> is the most common feature. Other symptoms include abdominal pain, unintentional weight loss, and a general feeling of being unwell (<a href=\"https://medlineplus.gov/ency/article/003089.htm\" target=\"_blank\">malaise</a>).[12368][12369]&nbsp;<br />\r\n<br />\r\nThe cause of Klatskin tumors is unknown.[3899] Studies suggest that a combination of genetic, environmental, and lifestyle factors (<a href=\"https://ghr.nlm.nih.gov/primer/mutationsanddisorders/complexdisorders\" target=\"_blank\">multifactorial</a>) likely influence whether a person will develop cholangiocarcinoma. Because Klatskin tumors are often discovered after they have spread, they can be challenging to treat.[12368] Surgical removal of the tumor and relief of bile duct blockage are the main goals of treatment.[3898][3899][12369]","dateModified":"2016-10-13T00:00:00"},"basicQuestions":[{"questionId":4909,"questionText":"What signs and symptoms&nbsp;may be&nbsp;associated with Klatskin tumors?","answerText":"The&nbsp;symptoms associated with Klatskin tumors are usually due to&nbsp;blocked bile ducts. Symptoms may include:[3898][3899][12368]\r\n<ul>\r\n    <li><a href=\"http://www.nlm.nih.gov/medlineplus/jaundice.html\" target=\"_blank\">Jaundice</a>\r\n    </li>\r\n    <li>Itching\r\n    </li>\r\n    <li>Light colored stools and/or dark urine\r\n    </li>\r\n    <li>Abdominal pain\r\n    </li>\r\n    <li>Loss of appetite / weight loss\r\n    </li>\r\n    <li>Fever\r\n    </li>\r\n    <li>Nausea / vomiting</li>\r\n</ul>","dateModified":"2016-10-13T00:00:00","resourceClassificationName":"Symptoms","references":[{"referenceId":3898,"authors":"","articleTitle":"Bile Duct (Cholangiocarcinoma) Cancer","bookWebsiteJournalTitle":"American Cancer Society","date":"November 1, 2014","volume":"","pages":"","url":"http://www.cancer.org/cancer/bileductcancer/detailedguide/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":3899,"authors":"Darwin PE","articleTitle":"Cholangiocarcinoma","bookWebsiteJournalTitle":"Medscape Reference","date":"August 9, 2016","volume":"","pages":"","url":"http://emedicine.medscape.com/article/277393-overview","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":12368,"authors":"","articleTitle":"Cholangiocarcinoma","bookWebsiteJournalTitle":"Genetics Home Reference (GHR)","date":"August 2016","volume":"","pages":"","url":"https://ghr.nlm.nih.gov/condition/cholangiocarcinoma","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":4911,"questionText":"What is the prognosis for individuals with Klatskin tumors?","answerText":"Most Klatskin tumors are diagnosed at an advanced stage.[3898][3899][12368][12369] The best long-term results are achieved with surgical intervention.[12369] The median survival of patients with non-resectable Klatskin tumors after palliative drainage is two to eight months.[3899] Complications include recurring bacterial <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000290.htm\" target=\"_blank\">cholangitis</a> and/or liver failure (<a href=\"https://medlineplus.gov/ency/article/000255.htm\" target=\"_blank\">cirrhosis</a>).[3899] The aim of palliative treatment is improvement in the patient&rsquo;s quality of life. This includes treating <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000215.htm\" target=\"_blank\">cholestasis</a> and cholangitis, which secondarily prolongs survival.[3901][3902]","dateModified":"2016-10-13T00:00:00","resourceClassificationName":"Prognosis","references":[{"referenceId":3898,"authors":"","articleTitle":"Bile Duct (Cholangiocarcinoma) Cancer","bookWebsiteJournalTitle":"American Cancer Society","date":"November 1, 2014","volume":"","pages":"","url":"http://www.cancer.org/cancer/bileductcancer/detailedguide/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":3899,"authors":"Darwin PE","articleTitle":"Cholangiocarcinoma","bookWebsiteJournalTitle":"Medscape Reference","date":"August 9, 2016","volume":"","pages":"","url":"http://emedicine.medscape.com/article/277393-overview","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":3901,"authors":"Lillemoe KD","articleTitle":"Klatskin tumors","bookWebsiteJournalTitle":"Surgical Treatment: Evidence-Based and Problem-Oriented","date":"2001","volume":"","pages":"","url":"","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":3902,"authors":"Witzigmann H, Wiedmann M, Wittekind C, Mossner J, Hauss J","articleTitle":"Therapeutical Concepts and Results for Klatskin Tumors","bookWebsiteJournalTitle":"Dtsch Arztebl Int","date":"Feb 2008","volume":"105(9)","pages":"156-161","url":"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2696740/?tool=pubmed","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":12368,"authors":"","articleTitle":"Cholangiocarcinoma","bookWebsiteJournalTitle":"Genetics Home Reference (GHR)","date":"August 2016","volume":"","pages":"","url":"https://ghr.nlm.nih.gov/condition/cholangiocarcinoma","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":12369,"authors":"Furuse J","articleTitle":"Klatskin tumor","bookWebsiteJournalTitle":"Orphanet","date":"September 2012","volume":"","pages":"","url":"http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=99978","authors2":"","placeOfPublication":"","publisher":""}]}],"references":[],"relatedDiseases":[],"gardCases":[{"caseId":31449,"abbreviatedInquiry":"My mom has been diagnosed with a Klatskin tumor. They tried to remove it but were unable to do so. What symptoms might develop as her condition progresses? Her eyesight has become blurred.&nbsp;Could this be related to her condition?","caseQuestions":[{"questionId":4908,"questionText":"What&nbsp;are Klatskin tumors?","answerText":"<strong>Klatskin tumors</strong> are are a type of <a href=\"https://ghr.nlm.nih.gov/condition/cholangiocarcinoma\" target=\"_blank\">cholangiocarcinoma</a> that begins in an area called the hilum, where the left and right bile ducts join and leave the liver. It is the most common type of cholangiocarcinoma, accounting for more than half of all cases.[3898][3899][12368][12369] Symptoms usually don't present until advanced stages of disease, when <a href=\"https://medlineplus.gov/jaundice.html\" target=\"_blank\">jaundice</a> is the most common feature. Other symptoms include abdominal pain, unintentional weight loss, and a general feeling of being unwell (<a href=\"https://medlineplus.gov/ency/article/003089.htm\" target=\"_blank\">malaise</a>).[12368][12369]&nbsp;<br />\r\n<br />\r\nThe cause of Klatskin tumors is unknown.[3899] Studies suggest that a combination of genetic, environmental, and lifestyle factors (<a href=\"https://ghr.nlm.nih.gov/primer/mutationsanddisorders/complexdisorders\" target=\"_blank\">multifactorial</a>) likely influence whether a person will develop cholangiocarcinoma. Because Klatskin tumors are often discovered after they have spread, they can be challenging to treat.[12368] Surgical removal of the tumor and relief of bile duct blockage are the main goals of treatment.[3898][3899][12369]","dateModified":"2016-10-13T00:00:00","references":[{"referenceId":3898,"authors":"","articleTitle":"Bile Duct (Cholangiocarcinoma) Cancer","bookWebsiteJournalTitle":"American Cancer Society","date":"November 1, 2014","volume":"","pages":"","url":"http://www.cancer.org/cancer/bileductcancer/detailedguide/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":3899,"authors":"Darwin PE","articleTitle":"Cholangiocarcinoma","bookWebsiteJournalTitle":"Medscape Reference","date":"August 9, 2016","volume":"","pages":"","url":"http://emedicine.medscape.com/article/277393-overview","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":12368,"authors":"","articleTitle":"Cholangiocarcinoma","bookWebsiteJournalTitle":"Genetics Home Reference (GHR)","date":"August 2016","volume":"","pages":"","url":"https://ghr.nlm.nih.gov/condition/cholangiocarcinoma","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":12369,"authors":"Furuse J","articleTitle":"Klatskin tumor","bookWebsiteJournalTitle":"Orphanet","date":"September 2012","volume":"","pages":"","url":"http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=99978","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":4909,"questionText":"What signs and symptoms&nbsp;may be&nbsp;associated with Klatskin tumors?","answerText":"The&nbsp;symptoms associated with Klatskin tumors are usually due to&nbsp;blocked bile ducts. Symptoms may include:[3898][3899][12368]\r\n<ul>\r\n    <li><a href=\"http://www.nlm.nih.gov/medlineplus/jaundice.html\" target=\"_blank\">Jaundice</a>\r\n    </li>\r\n    <li>Itching\r\n    </li>\r\n    <li>Light colored stools and/or dark urine\r\n    </li>\r\n    <li>Abdominal pain\r\n    </li>\r\n    <li>Loss of appetite / weight loss\r\n    </li>\r\n    <li>Fever\r\n    </li>\r\n    <li>Nausea / vomiting</li>\r\n</ul>","dateModified":"2016-10-13T00:00:00","resourceClassificationName":"Symptoms","references":[{"referenceId":3898,"authors":"","articleTitle":"Bile Duct (Cholangiocarcinoma) Cancer","bookWebsiteJournalTitle":"American Cancer Society","date":"November 1, 2014","volume":"","pages":"","url":"http://www.cancer.org/cancer/bileductcancer/detailedguide/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":3899,"authors":"Darwin PE","articleTitle":"Cholangiocarcinoma","bookWebsiteJournalTitle":"Medscape Reference","date":"August 9, 2016","volume":"","pages":"","url":"http://emedicine.medscape.com/article/277393-overview","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":12368,"authors":"","articleTitle":"Cholangiocarcinoma","bookWebsiteJournalTitle":"Genetics Home Reference (GHR)","date":"August 2016","volume":"","pages":"","url":"https://ghr.nlm.nih.gov/condition/cholangiocarcinoma","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":4910,"questionText":"What symptoms are&nbsp;common in patients with&nbsp;non-resectable Klatskin tumors?","answerText":"Two of the most common features noted in patients with non-resectable tumors are bile duct blockage (which can lead to jaundice, itching, and other symptoms) and pain.[3898][3899]","dateModified":"2016-10-13T00:00:00","resourceClassificationName":"Symptoms","references":[{"referenceId":3898,"authors":"","articleTitle":"Bile Duct (Cholangiocarcinoma) Cancer","bookWebsiteJournalTitle":"American Cancer Society","date":"November 1, 2014","volume":"","pages":"","url":"http://www.cancer.org/cancer/bileductcancer/detailedguide/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":3899,"authors":"Darwin PE","articleTitle":"Cholangiocarcinoma","bookWebsiteJournalTitle":"Medscape Reference","date":"August 9, 2016","volume":"","pages":"","url":"http://emedicine.medscape.com/article/277393-overview","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":4912,"questionText":"Is&nbsp;blurred vision associated with Klatskin tumor progression?","answerText":"A search of the resources available to us did not identify blurred vision as an associated finding in Klatskin tumors.&nbsp;We encourage you to discuss your concerns with your mom's health care providers.","dateModified":"2016-10-13T00:00:00","references":[]},{"questionId":4911,"questionText":"What is the prognosis for individuals with Klatskin tumors?","answerText":"Most Klatskin tumors are diagnosed at an advanced stage.[3898][3899][12368][12369] The best long-term results are achieved with surgical intervention.[12369] The median survival of patients with non-resectable Klatskin tumors after palliative drainage is two to eight months.[3899] Complications include recurring bacterial <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000290.htm\" target=\"_blank\">cholangitis</a> and/or liver failure (<a href=\"https://medlineplus.gov/ency/article/000255.htm\" target=\"_blank\">cirrhosis</a>).[3899] The aim of palliative treatment is improvement in the patient&rsquo;s quality of life. This includes treating <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000215.htm\" target=\"_blank\">cholestasis</a> and cholangitis, which secondarily prolongs survival.[3901][3902]","dateModified":"2016-10-13T00:00:00","resourceClassificationName":"Prognosis","references":[{"referenceId":3898,"authors":"","articleTitle":"Bile Duct (Cholangiocarcinoma) Cancer","bookWebsiteJournalTitle":"American Cancer Society","date":"November 1, 2014","volume":"","pages":"","url":"http://www.cancer.org/cancer/bileductcancer/detailedguide/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":3899,"authors":"Darwin PE","articleTitle":"Cholangiocarcinoma","bookWebsiteJournalTitle":"Medscape Reference","date":"August 9, 2016","volume":"","pages":"","url":"http://emedicine.medscape.com/article/277393-overview","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":3901,"authors":"Lillemoe KD","articleTitle":"Klatskin tumors","bookWebsiteJournalTitle":"Surgical Treatment: Evidence-Based and Problem-Oriented","date":"2001","volume":"","pages":"","url":"","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":3902,"authors":"Witzigmann H, Wiedmann M, Wittekind C, Mossner J, Hauss J","articleTitle":"Therapeutical Concepts and Results for Klatskin Tumors","bookWebsiteJournalTitle":"Dtsch Arztebl Int","date":"Feb 2008","volume":"105(9)","pages":"156-161","url":"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2696740/?tool=pubmed","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":12368,"authors":"","articleTitle":"Cholangiocarcinoma","bookWebsiteJournalTitle":"Genetics Home Reference (GHR)","date":"August 2016","volume":"","pages":"","url":"https://ghr.nlm.nih.gov/condition/cholangiocarcinoma","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":12369,"authors":"Furuse J","articleTitle":"Klatskin tumor","bookWebsiteJournalTitle":"Orphanet","date":"September 2012","volume":"","pages":"","url":"http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=99978","authors2":"","placeOfPublication":"","publisher":""}]}]}],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":12191,"phenoTypeName":"Cholangiocarcinoma","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":5967,"phenoTypeName":"Extrahepatic cholestasis","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":10276,"phenoTypeName":"Jaundice","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8115,"phenoTypeName":"Hepatomegaly","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13313,"phenoTypeName":"Lymphadenopathy","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13419,"phenoTypeName":"Abdominal pain","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13704,"phenoTypeName":"Fatigue","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13043,"phenoTypeName":"Fever","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":10903,"phenoTypeName":"Venous thrombosis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":5059,"phenoTypeName":"Weight loss","frequencyText":"Occasional","percentRanges":"5%-29%"}],"medicalProducts":[],"EncodedName":"Klatskin_tumor"}